C-reactive protein is an indicator for fatal outcomes in first-time stroke patients

Medical Science Monitor

Volumn 11, Issue 11, 2005, Pages

  Koçer, Abdulkadir ^a   Canbulat, Cüneyt ^a   Gözke, Eren ^a   Ilhan, Atllla ^b  

^a PTT Hospital   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

hsCRP; Ischemic stroke; Prognosis; Risk factors

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; MALE; MORTALITY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PROGNOSIS; RISK FACTOR; SERUM; STROKE;

AGED; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS;

EID: 28144443883     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Ridker PM, Hennekens CH, Buring JE et al: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med, 2000; 342: 836-43
2. Mendall MA, Strachan DP, Butland BK et al: C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J, 2000; 21: 1584-90
3. Ridker PM, Stampfer MJ, Rifai N: Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA, 2001; 285: 2481-85
4. Pye M, Rae AP, Cobbe SM: Study of serum C-reactive protein concentration in cardiac failure. Br Heart J, 1990; 63: 228-30
5. Curb JD, Abbott RD, Rodriguez BL et al: C-reactive protein and the future risk of thromboembolic stroke in healthy men. Circulation, 2003; 107: 2016-20
6. Cao JJ, Thach C, Manolio TA et al: C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study. Circulation, 2003; 108: 166-70
7. Pearson TA, Mensah GA, Alexander RW et al: Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for health-care professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 2003; 107: 499-511
8. Hatano S: Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ, 1976; 54: 541-53
9. Auer J, Berent R, Lassnig E, Eber B: C-reactive protein and coronary artery disease. Japan. Heart J, 2002; 43: 607-19
10. Berk BC, Weintraub WS, Alexander RW: Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol, 1990; 65: 168-72
11. Mendall MA, Strachan DP, Rutland BK et al: C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J, 2000; 21: 1584-90
12. Turkoglu EI, Gurgur C, Zoghi M, Turkoglu C: [The relationship between serum C-reactive protein levels and coronary artery disease in patients with stable angina pectoris and positive exercise stress test]. Anadolu Kardiyol Derg, 2004; 4: 199-202, Turkish
13. Haverkate F, Thompson SG, Pyke SDM et al for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Production of C-reactive protein and risk for coronary events in stable and unstable angina. Lancet, 1997; 349: 462-66
14. Ridker PM, Rifai N, Rose L et al: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med, 2002; 347: 1557-65
15. Auer J, Rammer M, Berent R et al: Relation of C-reactive protein levels to presence, extent, and severity of angiographic coronary artery disease. Indian Heart J, 2002; 54: 284-88
16. Yamashita H, Shimada K, Seki E et al: Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris. Am J Cardiol, 2003; 91: 133-36
17. Ross R: Atherosclerosis: an inflammatory disease. N Eng J Med, 1999; 340: 115-26
18. Hoshi T, Kitagawa K, Yamagami H et al: Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke, 2005; 36(4): 768-72
19. Yamagami H, Kitagawa K, Nagai Y et al: Higher levels of interleukin-6 are associated with lower echogenicity of carotid artery plaques. Stroke, 2004; 35(3): 677-81
20. Di Napoli M, Papa F, Bocola V: Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke, 2001; 32(1): 133-38
21. Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Eng J Med, 1999; 340: 448-54
22. Grau AJ: Infection, inflammation, and cerebrovascular ischemia. Neurology, 1997; 49: 47-51
23. Arenillas JF, Alvarez-Sabin J, Molina CA et al: C-reactive protein predicts further ischemic events in first ever transient ischemic attack or stroke patients with intracranial large artery occlusive disease. Stroke, 2003; 34: 2468-70
24. Di Napoli M, Papa F, Bocola V: C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke, 2001; 32(4): 917-24
25. Shah SH, Newby LK: C-reactive protein: A novel marker of cardiovascular risk. Cardiology in Review, 2003; 11: 169-79
26. Dev D, Wallace E, Sankaran R et al: Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease. Respir Med, 1998; 92: 664-67
27. Ridker PM, Rifai N, Clearfield M et al: Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med, 2001; 344: 1959-65
28. Ridker PM, Rifai N, Pfeffer MA et al: Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation, 1998; 98: 839-44
29. Cushman M, Legault C, Barret-Connor E et al: Effect of postmenopausal hormones on inflammation-sensitive proteins: Postmenopausal Estrogen/Progestin Interventions (PEPI) study. Circulation, 1999; 100: 717-22
30. Ridker PM, Hennekens CH, Rifai N et al: Hormone replacement therapy and increased plasma concentration of Creactive protein. Circulation, 1999; 100: 713-16
31. Ylikorkala O, Evio S, Valimaki M et al: Effects of hormone therapy and alendronate on C-reactive protein, E-selectin, and sex hormone-binding globulin in osteoporotic women. Fertil Steril, 2003; 80: 541-45
32. Di Napoli M, Papa F: C-reactive protein and blood pressure in the acute phase after an ischemic stroke. Stroke, 2003; 34(4): 839
33. Engstrom G, Lind P, Hedblad B et al: Long-term effects of inflammation-sensitive plasma proteins and systolic blood pressure on incidence of stroke. Stroke, 2002; 33(12): 2744-49